![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C9H13N3 |
Molar mass | 163.224 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
ABT-202 is a drug developed byAbbott, which acts as an agonist at neuralnicotinic acetylcholine receptors and has been researched for use as ananalgesic, although it has not passedclinical trials.[1][2][3]